Every product is produced under rigorous quality control to ensure purity and potency
Leading participants such as Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca PLC, Boehringer Ingelheim GmbH, Merck & Co., Inc., Amgen Inc., GSK plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, Bayer AG, Johnson & Johnson, Regeneron Pharmaceuticals, Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC contribute to innovation, geographic expansion, and service delivery in this space
In Brazil, for example, the GLP-1 market could more than quadruple, with generic competition potentially reducing prices by up to 70%
Theoretically, these complementary mechanisms could support metabolic function, though there is no established evidence that taking both supplements provides superior glucose control compared to either alone
PubMed PMID: 11459660